Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial
NCT03032666
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Thalassemia
Hepatitis C
Interventions
DRUG:
sofosbuvir/velpatasvir
Sponsor
Ala'a Sharara
Collaborators
[object Object]